综合类等试验设备
Search documents
苏试试验(300416):25Q4业绩环比高增 有望受益于商业航天新景气
Xin Lang Cai Jing· 2026-01-21 00:37
业绩简评 2026 年1 月20 日,公司发布2025 年度业绩预告,经营业绩实现增长:25 年归母净利润2.45-2.65 亿元, 同比增长6.8%-15.51%;扣非净利润2.33-2.53 亿元,同比增长12.22%-21.86%。其中,25Q4 单季实现归 母净利润8816 万-1.08 亿,同比增长6.2%-30.3%,环比增长123%-173%;实现扣非净利润8351 万-1.04 亿,同比增长9.3%-35.5%,环比增长137%-194%。 经营分析 25Q4 单季业绩环比高增,或系下游景气修复所致:1)公司坚持"聚焦主业、双轮驱动、制造与服务融 合发展"战略,25 全年归母净利润2.45-2.65 亿元,同比增长6.8%-15.51%,实现稳健增长。2)25Q4 单 季实现归母净利润8816 万-1.08 亿,同比增长6.2-30.3%,环比增长123%-173%。3)我们认为,公司 25Q4 单季业绩环比高增,或系不利因素消除、下游景气修复,以及商业航天等新质新域业务增长所 致。 精准把握航空航天专业测试需求,有望受益商业航天新景气:1)持续推进试验设备技术创新,以热真 空、低气压、液压类 ...
苏试试验(300416):25Q4业绩环比高增,有望受益于商业航天新景气
SINOLINK SECURITIES· 2026-01-20 15:35
Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected price increase of over 15% in the next 6-12 months [4][9]. Core Views - The company is expected to achieve steady growth in its performance, with a projected net profit of RMB 2.45-2.65 billion for 2025, representing a year-on-year increase of 6.8%-15.51% [2][4]. - The significant quarter-on-quarter growth in Q4 2025 is attributed to the recovery of downstream demand and the growth of new business areas such as commercial aerospace [2][3]. Summary by Sections Performance Overview - For the full year of 2025, the company anticipates a net profit of RMB 2.45-2.65 billion, with a year-on-year growth of 6.8%-15.51% [2]. - In Q4 2025, the company expects a net profit of RMB 88.16-108 million, showing a year-on-year increase of 6.2%-30.3% and a quarter-on-quarter increase of 123%-173% [2][4]. Business Strategy and Market Position - The company focuses on its core business and aims for a dual-driven strategy that integrates manufacturing and services [2]. - It is actively expanding into new sectors, including commercial aerospace, and has signed a project cooperation agreement with the Hangzhou Yunqi Town Management Committee, planning to invest at least RMB 300 million [3]. Financial Projections - The projected net profits for 2025-2027 are RMB 2.57 billion, RMB 3.31 billion, and RMB 3.99 billion, with respective year-on-year growth rates of 12.08%, 28.85%, and 20.56% [4]. - The company’s price-to-earnings (P/E) ratios are expected to be 35, 27, and 23 for the years 2025, 2026, and 2027, respectively [4]. Market Trends and Opportunities - The company is positioned to benefit from high-growth sectors such as military, semiconductor, new energy, and commercial aerospace [4]. - Continuous innovation in testing equipment and expanding laboratory qualifications are key strategies to enhance its market presence [3].